Amdoxovir

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameAmdoxovir
Drug Alias Name安多索韦amdoxovirum氨多索韦AMDXDAPD
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHuman immunodeficiency virus type 1 reverse transcriptase inhibitors
TargetsHuman immunodeficiency virus type 1 reverse transcriptase
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPuerto RicoArgentina
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEmory UniversityUniversity Of Georgia
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRfs Pharma LlcNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG